About Zumutor

This author has not yet filled in any details.
So far Zumutor has created 10 blog entries.

Zumutor Biologics Announces Receipt of a Grant from The United States – India Science & Technology Endowment Board

By |2020-09-07T12:09:54+05:30September 7th, 2020|

We are pleased to announce that we have received a grant from the USISTEF to advance our program for the development of monoclonal antibody therapeutics for the treatment of COVID-19. This is a collaborative project in partnership with Prof. Shiladitya Sengupta (Brigham and Women’s Hospital, Cambridge, MA). The novel coronavirus pandemic has created an unprecedented [...]

INABLRS® – End to end antibody discovery platform

By |2020-09-07T12:09:45+05:30August 18th, 2020|

Major strategies for mining human antibody repertoires are: a) non-combinatorial and b) combinatorial strategies. Non-combinatorial strategies retrieve human Monoclonal Antibodies (mAbs) from single B-cells with the original heavy and light chain pairs while combinatorial strategies involve human antibody library with randomly combined heavy and light chains. Both approaches have led to food and drug [...]

Training a Natural Killer!

By |2020-09-07T12:09:45+05:30June 22nd, 2020|

- By Aniket Bangroo, Kirthana MV Sindhe and Subhra Prakash Chakrabarty - Cancer is a formidable disease that may arise when some cells of our body behave in an anomalous fashion giving rise to tumors marked by abnormal growth, cell survivability and the ability to escape immune surveillance. The immune system of our body, [...]

Catalent and Zumutor Biologics Collaborate to Manufacture First-in-Class mAb to Treat Solid Tumors

By |2020-09-07T12:09:46+05:30February 12th, 2020|

Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced that it has signed an agreement with Zumutor Biologics, Inc., to manufacture Zumutor’s lead candidate, ZM008, for the treatment of solid tumors. Zumutor is a biologics company that [...]

Zumutor Biologics raises $ 4 million in Series A2 funding

By |2020-09-07T12:09:46+05:30November 29th, 2019|

Zumutor Biologics, an Immuno-Oncology company developing novel mABs to drive transformational changes in the treatment of cancer raises 4Mil$ in series A2 funding taking its total raise to 20Mil$. The round includes funding by new investor Bharat Innovation Fund (BIF) with participation from its existing investor, Accel Partners. Zumutor’s growth strategy is focused on [...]

Dr. Maloy Ghosh, Chief Scientific Officer at Zumutor Biologics Inc spoke on “ Human Antibody Library Development for therapeutic monoclonal antibody products” at INNO 2018

By |2020-09-07T12:09:46+05:30December 4th, 2018|

Dr. Maloy Ghosh, Chief Scientific Officer at Zumutor Biologics Inc spoke on “ Human Antibody Library Development for therapeutic monoclonal antibody products” at INNO 2018, a two-day Antibody Symposium held on Monday, 3rd  December 2018, in Bengaluru, India. The symposium was designed  to expand the understanding of scientific advancements in antibody conjugates. Participants  included global [...]

Advances in Metastatic Castration Resistant Prostate Cancer (mCRPC) Management

By |2020-09-07T12:09:46+05:30November 29th, 2018|

- By Sonali Karhana -  Despite recent diagnostic and therapeutic advances, prostate adenocarcinoma is the second most common cancer in the Western male population. One in 7 men over the age of 50 years are diagnosed with prostate cancer at some point in their lives. “The first step toward ending this disease, which takes the [...]

Natural Killer Cells are Crucial to Generating Robust Anti-Tumor Immune Response

By |2020-09-07T12:09:46+05:30September 11th, 2018|

- By Ramon Valencia, Vice president-Corporate Development & Strategy -  The focus of immunotherapy  over the last decade has been activating or re-activating T cells.  A lesser known, but no less important to healthy immune function, is an immune cell called a natural killer (NK) cell.  .   NK cells “natural killer” are named so [...]